Clinical Trials Browser

Margins of Excision × Genitourinary × 1 year × Clear all

Margins of Excision, Adenocarcinoma, Prostatic Neoplasms

NCT07517198 2026-04-08

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Margins of Excision, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Liver Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT07141121 2025-10-07

IMARHGIN

Phase NA Recruiting

78 enrolled

Genitourinary

Margins of Excision, Prostatic Neoplasms

Clinical Trials

LaserSAFE

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

IMARHGIN